Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Myeloablative single-unit cord blood transplantation overcomes the negative prognostic impact of FLT3-ITD in adult acute myeloid leukemia.

Konuma T, Kato S, Oiwa-Monna M, Mizusawa M, Isobe M, Yokoyama K, Takahashi S, Tojo A.

Leuk Lymphoma. 2019 Feb 18:1-4. doi: 10.1080/10428194.2019.1579325. [Epub ahead of print] No abstract available.

PMID:
30775946
2.

Development of pre-engraftment syndrome, but not acute graft-versus-host disease, reduces relapse rate of acute myeloid leukemia after single cord blood transplantation.

Isobe M, Konuma T, Kato S, Tanoue S, Mizusawa M, Oiwa-Monna M, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2019 Feb 13. pii: S1083-8791(19)30132-6. doi: 10.1016/j.bbmt.2019.02.007. [Epub ahead of print]

PMID:
30771495
3.

The Prognostic Impact of Pretransplantation Inflammatory and Nutritional Status in Adult Patients after Myeloablative Single Cord Blood Transplantation.

Miyashita E, Konuma T, Kataoka J, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Sato T, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2019 Jan 11. pii: S1083-8791(19)30014-X. doi: 10.1016/j.bbmt.2019.01.006. [Epub ahead of print]

PMID:
30639818
4.

Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose Total Body Irradiation/Granulocyte Colony-Stimulating Factor-Combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients with Nonremission Myeloid Malignancies.

Konuma T, Kato S, Isobe M, Mizusawa M, Oiwa-Monna M, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2018 Dec 7. pii: S1083-8791(18)30803-6. doi: 10.1016/j.bbmt.2018.12.004. [Epub ahead of print]

PMID:
30529460
5.

Risk factors and survival impact of readmission after single-unit cord blood transplantation for adults.

Yamagishi Y, Konuma T, Miwa Y, Oiwa-Monna M, Tanoue S, Isobe M, Jimbo K, Mizusawa M, Narita H, Kobayashi K, Kato S, Takahashi S, Tojo A.

Int J Hematol. 2019 Jan;109(1):115-124. doi: 10.1007/s12185-018-2539-7. Epub 2018 Oct 9.

PMID:
30302739
6.

Efficacy and Safety of Low-Dose Liposomal Amphotericin B in Adult Patients Undergoing Unrelated Cord Blood Transplantation.

Yasu T, Konuma T, Oiwa-Monna M, Kato S, Tanoue S, Isobe M, Mizusawa M, Kuroda S, Takahashi S, Tojo A.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01205-18. doi: 10.1128/AAC.01205-18. Print 2018 Nov.

PMID:
30104271
7.

Does marital status affect the outcomes after allogeneic hematopoietic cell transplantation?

Sato T, Konuma T, Oiwa-Monna M, Tanoue S, Isobe M, Jimbo K, Kasuya F, Hisahara M, Kobayashi K, Kato S, Takahashi S, Tojo A.

Bone Marrow Transplant. 2018 Jun;53(6):774-779. doi: 10.1038/s41409-018-0217-2. Epub 2018 May 24. No abstract available.

PMID:
29795421
8.

Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes.

Tanoue S, Konuma T, Kato S, Oiwa-Monna M, Isobe M, Jimbo K, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1873-1880. doi: 10.1016/j.bbmt.2018.05.006. Epub 2018 May 10.

PMID:
29753839
9.

Circulating monocyte subsets in human chronic graft-versus-host disease.

Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Oiwa-Monna M, Tanoue S, Isobe M, Jimbo K, Kato S, Takahashi S, Tojo A.

Bone Marrow Transplant. 2018 Dec;53(12):1532-1540. doi: 10.1038/s41409-018-0187-4. Epub 2018 May 4.

PMID:
29728699
10.

A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation.

Sato T, Konuma T, Miwa Y, Sugihara N, Tsuru Y, Narita H, Kiriyama S, Kato S, Oiwa-Monna M, Kobayashi K, Takahashi S, Tojo A.

Ann Hematol. 2017 Nov;96(11):1841-1847. doi: 10.1007/s00277-017-3087-6. Epub 2017 Aug 16.

PMID:
28815326
11.

Cytokine Profiles of Pre-Engraftment Syndrome after Single-Unit Cord Blood Transplantation for Adult Patients.

Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Oiwa-Monna M, Tanoue S, Isobe M, Kato S, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1932-1938. doi: 10.1016/j.bbmt.2017.07.020. Epub 2017 Jul 26.

12.

Alloimmune hemolysis due to major RhE incompatibility after unrelated cord blood transplantation.

Isobe M, Konuma T, Abe-Wada Y, Hirata K, Ogami K, Kato S, Oiwa-Monna M, Tanoue S, Nagamura-Inoue T, Takahashi S, Tojo A.

Leuk Lymphoma. 2018 Apr;59(4):1000-1003. doi: 10.1080/10428194.2017.1352095. Epub 2017 Jul 20. No abstract available.

PMID:
28727478
13.

Severe infusion-related toxicity after a second unrelated cord blood transplantation.

Tanoue S, Konuma T, Kato S, Oiwa-Monna M, Isobe M, Tojo A, Takahashi S.

Cytotherapy. 2017 Aug;19(8):1013-1014. doi: 10.1016/j.jcyt.2017.05.004. Epub 2017 Jun 20. No abstract available.

PMID:
28645732
14.

Cryopreserved CD34+ Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients.

Konuma T, Kato S, Oiwa-Monna M, Tanoue S, Ogawa M, Isobe M, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1142-1150. doi: 10.1016/j.bbmt.2017.03.036. Epub 2017 Apr 5.

15.

Impact of hematogones on the long-term outcomes of single-unit cord blood transplantation for adult patients.

Ishii H, Konuma T, Kato S, Oiwa-Monna M, Tojo A, Takahashi S.

Leuk Lymphoma. 2017 Jan;58(1):118-126. Epub 2016 May 17.

PMID:
27184125
16.

Early phase mixed chimerism in bone marrow does not affect long-term outcomes of myeloablative single-unit cord blood transplantation for adult patients with hematological malignancies.

Konuma T, Kato S, Oiwa-Monna M, Ishii H, Tojo A, Takahashi S.

Leuk Lymphoma. 2016 Dec;57(12):2848-2854. Epub 2016 Apr 28.

PMID:
27124418
17.
18.

Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation.

Konuma T, Kato S, Ooi J, Ebihara Y, Mochizuki S, Ishii H, Takei T, Oiwa-Monna M, Tojo A, Takahashi S.

Leuk Lymphoma. 2016;57(1):103-9. doi: 10.3109/10428194.2015.1045900. Epub 2015 May 25.

PMID:
25926066
19.

Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.

Konuma T, Kato S, Ishii H, Oiwa-Monna M, Asano S, Tojo A, Takahashi S.

Leuk Res. 2015 Jun;39(6):625-31. doi: 10.1016/j.leukres.2015.03.022. Epub 2015 Apr 7.

PMID:
25888304
20.

HLA-DRB1 mismatch is associated with a decreased relapse in adult acute myeloid leukemia after single-unit myeloablative cord blood transplantation.

Konuma T, Kato S, Ishii H, Takeda R, Oiwa-Monna M, Tojo A, Takahashi S.

Ann Hematol. 2015 Jul;94(7):1233-5. doi: 10.1007/s00277-015-2347-6. Epub 2015 Mar 11. No abstract available.

PMID:
25754345
21.

Third allogeneic stem cell transplantation (SCT) using unrelated cord blood for relapsed acute leukemia after second allogeneic SCT.

Konuma T, Kato S, Ooi J, Ebihara Y, Mochizuki S, Oiwa-Monna M, Tojo A, Takahashi S.

Int J Hematol. 2015 Apr;101(4):392-7. doi: 10.1007/s12185-015-1755-7. Epub 2015 Feb 6.

PMID:
25655380
22.

Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Tojo A, Takahashi S.

Ann Hematol. 2015 Feb;94(2):289-96. doi: 10.1007/s00277-014-2195-9. Epub 2014 Sep 3.

PMID:
25178518
23.

Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide.

Konuma T, Kato S, Oiwa-Monna M, Tojo A, Takahashi S.

Leuk Lymphoma. 2015 Apr;56(4):1148-50. doi: 10.3109/10428194.2014.949261. Epub 2014 Sep 8. No abstract available.

PMID:
25093379
24.

Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Kawamata T, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1150-5. doi: 10.1016/j.bbmt.2014.04.005. Epub 2014 Apr 13.

25.

Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Tojo A, Takahashi S.

Bone Marrow Transplant. 2014 May;49(5):634-9. doi: 10.1038/bmt.2014.10. Epub 2014 Feb 17.

PMID:
24535130
26.

Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Apr;20(4):577-81. doi: 10.1016/j.bbmt.2013.12.563. Epub 2013 Dec 22.

27.

Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Asano S, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Mar;20(3):396-401. doi: 10.1016/j.bbmt.2013.12.555. Epub 2013 Dec 11.

28.

Pretransplant hyperferritinemia has no effect on the outcome of myeloablative cord blood transplantation for acute leukemia and myelodysplastic syndrome.

Konuma T, Kato S, Oiwa-Monna M, Tojo A, Takahashi S.

Ann Hematol. 2014 Jun;93(6):1071-2. doi: 10.1007/s00277-013-1932-9. Epub 2013 Oct 19. No abstract available.

PMID:
24141336
29.

Early renal injury after myeloablative cord blood transplantation in adults.

Mae H, Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Hongo E, Kato S, Kasahara S, Oiwa-Monna M, Kurokawa Y, Tojo A, Asano S.

Leuk Lymphoma. 2008 Mar;49(3):538-42. doi: 10.1080/10428190701824577.

PMID:
18297532
30.

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.

Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, Fukuno K, Uchiyama M, Takasugi K, Iseki T, Tojo A, Yamaguchi T, Asano S.

Blood. 2007 Feb 1;109(3):1322-30. Epub 2006 Oct 12.

Supplemental Content

Loading ...
Support Center